OrbiMed Asia Partners IV, L.P. — Form D
OrbiMed Asia Partners IV, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-03-05. The offering totals $750.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-03-05
- Form: D
- Accession: 0001796011-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $750.0M
- Remaining: $750.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-362067
Issuer
- Name: OrbiMed Asia Partners IV, L.P.
- CIK: 0001796011
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY, 10022
- Phone: 2127396400
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| W. Carter Neild | Director | NEW YORK, NY |
| Sven H Borho | Director | New York, NY |
| David G Wang | Director | Shanghai, F4 |
| Jonathan T Silverstein | Director | New York, NY |
| N/A OrbiMed Asia GP IV, L.P. | Executive Officer | New York, NY |
| N/A OrbiMed Asia GP IV, L.P. | Promoter | New York, NY |
| N/A OrbiMed Advisors IV Limited | Executive Officer | New York, NY |
| N/A OrbiMed Advisors IV Limited | Promoter | New York, NY |
| Sunny T Sharma | Director | Mumbai, K7 |
| Carl L Gordon | Director | Stamford, CT |
Other filings by this issuer (1)
More